Allergan Pharmaceuticals (688373.SH) shareholder Genie Pharma has submitted a request to increase the temporary proposal involving the removal and election of directors.

Intelligence Finance APP News, Mengke Pharmaceutical (688373.SH) announced that the company's shareholder Genie Pharma proposed an interim proposal on September 24, 2025, to increase the agenda for the second interim shareholders meeting in 2025 to include a motion to dismiss ZHENGYU YUAN, Li Zhile, and Wu Pancheng from the company's second board and a motion to elect Yang Zongfan, Wang Yong, and Xu Yuchao as directors of the company's second board. The shareholders meeting was originally scheduled to be held on October 9, 2025. After adding the interim proposal, the agenda for review includes the original and additional director dismissal and election proposals.